Literature DB >> 9162037

Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH.

Y Chen1, W H Fischer, G N Gill.   

Abstract

Within the human ERBB-2 gene promoter, a 100-base pair region 5' to the TATA box enhances basal transcription 200-fold. Two palindromes present within this 100-base pair region are important for transcription. The palindrome binding protein was purified to homogeneity and found to be identical to RBPJkappa, the mammalian homolog of Drosophila Suppressor of Hairless (Su(H)). Recombinant RBPJkappa bound the ERBB-2 promoter with affinity comparable with that seen with well characterized RBPJkappa binding sites. RBPJkappa activated an ERBB-2 palindrome-containing promoter in 293 cells. Because in Drosophila Su(H) acts downstream of NOTCH and because NOTCH.Su(H)/RBPJkappa stimulates transcription from target promoters, NOTCH-IC, a constitutively active form of NOTCH, was tested for effects on the ERBB-2 palindrome. NOTCH-IC further increased RBPJkappa-mediated transcription on wild type but not mutant ERBB-2 palindrome. Thus, RBPJkappa can activate ERBB-2 transcription and serve as an anchor to mediate NOTCH function on the ERBB-2 gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9162037     DOI: 10.1074/jbc.272.22.14110

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway.

Authors:  Boris Reizis; Philip Leder
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

Review 2.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 3.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 4.  Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

Authors:  Wen Shi; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

5.  Cellular target genes of Epstein-Barr virus nuclear antigen 2.

Authors:  Sabine Maier; Gabriele Staffler; Andrea Hartmann; Julia Höck; Karen Henning; Kristina Grabusic; Reinhard Mailhammer; Reinhard Hoffmann; Matthias Wilmanns; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  The Notch signaling pathway is related to neurovascular progression of pancreatic cancer.

Authors:  Peter Büchler; Amiq Gazdhar; Mario Schubert; Nathalia Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Güralp O Ceyhan; Michael Müller; Markus W Büchler; Helmut Friess
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

7.  Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.

Authors:  P Zhang; Y Yang; R Nolo; P A Zweidler-McKay; D P M Hughes
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

8.  Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex.

Authors:  Ralf S Schmid; Barbara McGrath; Bridget E Berechid; Becky Boyles; Mark Marchionni; Nenad Sestan; Eva S Anton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-20       Impact factor: 11.205

9.  Uncovering Notch pathway in the parasitic flatworm Schistosoma mansoni.

Authors:  Lizandra G Magalhães; Enyara R Morais; Carla B Machado; Matheus S Gomes; Fernanda J Cabral; Julia M Souza; Cláudia S Soares; Renata G Sá; William Castro-Borges; Vanderlei Rodrigues
Journal:  Parasitol Res       Date:  2016-06-25       Impact factor: 2.289

10.  Prognostic values of Notch receptors in breast cancer.

Authors:  Junming Xu; Fangbin Song; Tao Jin; Jun Qin; Junyi Wu; Min Wang; Ye Wang; Jun Liu
Journal:  Tumour Biol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.